Showing 121 - 140 results of 33,164 for search '(( significant spatial decrease ) OR ( significant ((genes decrease) OR (mean decrease)) ))', query time: 0.65s Refine Results
  1. 121

    Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

    Published 2021
    “…Abbreviations: GlcCer, glucosylceramide; GlcSph, glucosylsphingosine; <i>GBA1</i>, gene encoding human glucocerebrosidase; GCase, glucocerebrosidase; WT, wild type; HET, heterozygous; KI, knockin; SEM, standard error of the mean; mo, month; ns, non-significant (<i>p</i> > 0.05).…”
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126

    S1 Data - by Ying Xie (50016)

    Published 2024
    Subjects:
  7. 127
  8. 128
  9. 129

    Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3. by Martin Selinger (3195987)

    Published 2019
    “…Data are representative of three independent experiments and values are expressed as mean with SEM. Significant difference from the control was calculated using one-sample Student’s t-test (* P<0.05). …”
  10. 130
  11. 131
  12. 132
  13. 133
  14. 134
  15. 135

    MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

    Published 2025
    “…(n = 3 - 10 mice per group; Data are presented as the mean ± standard error; *, **, ***, and **** indicate significance at p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively.).…”
  16. 136
  17. 137

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
  18. 138
  19. 139
  20. 140